A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
This is a double-blind study evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR)
versus placebo in the Treatment of Children and Adolescent Outpatients with Major Depressive
Disorder (MDD).